Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

49 PIC/S Inspectorates Test-Drive Data Integrity Guidance

Executive Summary

Pharmaceutical Inspection Cooperation Scheme member inspectorates are trying out the most comprehensive manufacturing data integrity guidance yet developed. Issued amid a flurry of guidance from various authorities, it could play a key role in harmonizing regulatory approaches.

Advertisement

Related Content

EMA Clarifies Compliance With ALCOA Principles Is Key To Meeting Data Integrity Expectations
UK MHRA Aims To Address "Fundamental Failures" In Data Integrity
WHO Tackles Submission Of Insufficient Or False Data By Pharma
FDA Collates GMP Data Integrity Advice Into Draft Guidance
UK MHRA outlines data integrity expectations for pharma industry
Inspectorates Share QRM Tools to Protect Quality from Downsizing

Topics

Advertisement
UsernamePublicRestriction

Register

PS118995

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel